---
title: "Jiangsu held a symposium on the high-quality development of listed companies in the province to promote the long-term stable and healthy development of the capital market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235334585.md"
description: "On April 9th, the Jiangsu Provincial Financial Office and the Jiangsu Securities Regulatory Bureau held a symposium on the high-quality development of listed companies in the province, analyzing the short-term fluctuations and long-term stability trends of the capital market, and emphasizing high-quality development to cope with external uncertainties. During the meeting, representatives from 9 listed companies, including Hengrui Pharma and SUMEC, exchanged views, aiming to promote the healthy development of listed companies, maintain the stable operation of the capital market, and provide support for economic development"
datetime: "2025-04-10T02:49:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235334585.md)
  - [en](https://longbridge.com/en/news/235334585.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235334585.md)
generator: "portal-rs"
---

# Jiangsu held a symposium on the high-quality development of listed companies in the province to promote the long-term stable and healthy development of the capital market

On April 9th, the Jiangsu Provincial Financial Office and the Jiangsu Securities Regulatory Bureau jointly held a symposium on the high-quality development of listed companies in the province, objectively analyzing the short-term fluctuations of the capital market and the long-term trend of stability and improvement. They emphasized the importance of confidence, maintaining composure, and gathering strength to use the certainty of their own high-quality development to hedge against the uncertainties of the external environment. The meeting aimed to fully leverage the functions of the capital market to promote the healthy and high-quality development of listed companies, implement strong measures to maintain the healthy and stable operation of the capital market, and provide strong support for the economic powerhouse. Representatives from nine listed companies, including Hengrui Pharma, SUMEC, Aotegia, and Huatai Securities, exchanged views at the meeting

### Related Stocks

- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [600710.CN](https://longbridge.com/en/quote/600710.CN.md)
- [002239.CN](https://longbridge.com/en/quote/002239.CN.md)
- [06886.HK](https://longbridge.com/en/quote/06886.HK.md)

## Related News & Research

- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [EXPLAINER-The super peso is back — and it's starting to hurt](https://longbridge.com/en/news/296961066.md)
- [10:20 ETTEAMSTERS AT CASS-CLAY CREAMERY RATIFY CONTRACT](https://longbridge.com/en/news/296929253.md)
- [Stick with value stocks until everyone is talking about them - and they are still under the radar, this Wall Street firm says.](https://longbridge.com/en/news/296903252.md)
- [BeOne says FDA approves Tevimbra-based first-line regimen for HER2+ gastroesophageal cancer](https://longbridge.com/en/news/296930925.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**